Latest news in cancer
Lorlatinib has been approved by the FDA for the treatment of metastatic ALK-positive NSCLC.
August 2021: Lorlatinib (Lorbrena, Pfizer Inc.) received regular FDA approval for patients with metastatic non-small cell lung cancer (NSCLC) whose tumours are...
The FDA has granted axicabtagene ciloleucel expedited approval for relapsed or refractory follicular lymphoma.
August 2021: The FDA has given axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) expedited approval for adult patients with relapsed or refractory...
Lorlatinib has been approved by the FDA for the treatment of metastatic ALK-positive NSCLC
August 2021: Lorlatinib (Lorbrena, Pfizer Inc.) received regular FDA approval for patients with metastatic non-small cell lung cancer (NSCLC) whose tumours are...
Melphalan flufenamide receives approval from the FDA for relapsed or refractory multiple myeloma
August 2021: Melphalan flufenamide (Pepaxto, Oncopeptides AB) in combination with dexamethasone has been granted accelerated approval by the Food and Drug...
Cemiplimab-rwlc has been approved by the FDA for non-small cell lung cancer with high PD-L1 expression
August 2021: The FDA approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) for the first-line treatment of patients with advanced non-small cell...
Cemiplimab-rwlc has been approved by the FDA for the treatment of locally progressed and metastatic basal cell carcinoma
August 20, 2021: The FDA has given cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) regular approval for patients with locally advanced basal cell...
The FDA has approved the first targeted therapy for a lung cancer mutation that was previously thought to be drug-resistant
August 20, 2021: Recently in May, 2021 Lumakras (sotorasib) was approved by the US Food and Drug Administration as the first treatment for adult patients with...
Updated guidelines for food and physical activities for cancer patients
July 2021: The American Cancer Society has modified its cancer preventive diet and physical activity guidelines. A person’s lifetime risk of acquiring or...
Pembrolizumab approved for use in any cancer with a high tumor mutational burden
July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any...
Liver cancer surgery and transplant by Dr. Selvakumar
July 14, 2021: Check out interview of Dr. Selvakumar Naganathan – Clinical Lead – Liver transplantation and HPB surgery, Apollo Hospitals,...
Atezolizumab plus Bevacizumab for treatment of liver cancer
July 13th 2021: A novel medication for people with a kind of liver cancer called hepatocellular carcinoma is available that appears to be better than standard...
Beta Thalassemia and its consideration with COVID-19
July 2021: Beta-thalassemia is an inherited condition caused by mutations in a gene involved in the production of a component of haemoglobin, the protein that...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.